EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A 3D Pancreatic Cancer Model with Integrated Optical Sensors for Noninvasive Metabolism Monitoring and Drug Screening

Anna Chiara Siciliano, Stefania Forciniti, Valentina Onesto, Helena Iuele, Donatella Delle Cave, Federica Carnevali, Giuseppe Gigli, Enza Lonardo, Loretta L Del Mercato iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202401138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Anna Chiara Siciliano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nanotechnology, National Research Council (Cnr-NANOTEC), c/o Campus Ecotekne, via Monteroni, Lecce, 73100, Italy. Hauptthemen laut MEDLINE: Drug Screening Assays, Antitumor, Pancreatic Neoplasms, Antineoplastic Agents, Models, Biological. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC), H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Nanotechnologies, Associazione Italiana per la Ricerca contro il Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A distinct feature of pancreatic ductal adenocarcinoma (PDAC) is a prominent tumor microenvironment (TME) with remarkable cellular and spatial heterogeneity that meaningfully impacts disease biology and treatment resistance. The dynamic crosstalk between cancer cells and the dense stromal compartment leads to spatially and temporally heterogeneous metabolic alterations, such as acidic pH that contributes to drug resistance in PDAC. Thus, monitoring the extracellular pH metabolic fluctuations within the TME is crucial to predict and to quantify anticancer drug efficacy. Here, a simple and reliable alginate‐based 3D PDAC model embedding ratiometric optical pH sensors and cocultures of tumor (AsPC‐1) and stromal cells for simultaneously monitoring metabolic pH variations and quantify drug response is presented. By means of time‐lapse confocal laser scanning microscopy (CLSM) coupled with a fully automated computational analysis, the extracellular pH metabolic variations are monitored and quantified over time during drug testing with gemcitabine, folfirinox, and paclitaxel, commonly used in PDAC therapy. In particular, the extracellular acidification is more pronounced after drugs treatment, resulting in increased antitumor effect correlated with apoptotic cell death. These findings highlight the importance of studying the influence of cellular metabolic mechanisms on tumor response to therapy in 3D tumor models, this being crucial for the development of personalized medicine approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Screening Assays, AntitumorPancreatic NeoplasmsAntineoplastic AgentsModels, BiologicalHumansApoptosisCell Line, TumorDrug Resistance, NeoplasmHydrogen-Ion ConcentrationMicrogelsStromal CellsTumor MicroenvironmentGemcitabinePaclitaxelAntineoplastic Combined Chemotherapy ProtocolsLeucovorinFluorouracilIrinotecanOxaliplatin

Stichwörter der Autor:innen

alginate microgelsdrug testingfluorescence imaging and image segmentationoptical ratiometric pH sensorstumor microenvironment

Substanzen

MicrogelsAntineoplastic AgentsGemcitabinePaclitaxelfolfirinoxLeucovorinFluorouracilIrinotecanOxaliplatin

Autor:innen und Institutionen

  • Institute of Nanotechnology, National Research Council (Cnr-NANOTEC), c/o Campus Ecotekne, via Monteroni, Lecce, 73100, Italy.
  • Department of Mathematics and Physics "Ennio De Giorgi", University of Salento, c/o Campus Ecotekne, via Monteroni, Lecce, 73100, Italy.
  • Institute of Genetics and Biophysics Adriano Buzzati-Traverso, National Research Council (Cnr-IGB), Naples, 80131, Italy.
  • Department of Experimental Medicine, University of Salento, c/o Campus Ecotekne, via Monteroni, Lecce, 73100, Italy.

ORCID-Profile: Loretta L Del Mercato

Förderung

  • H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)
  • H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Nanotechnologies
  • Associazione Italiana per la Ricerca contro il Cancro
  • National Recovery and Resilience Plan co-funded by NextGenerationEU
  • YoungResearcher_PNRR
  • Apulia Region

Zitieren

APA

Siciliano, A. C., Forciniti, S., Onesto, V., Iuele, H., Cave, D. D., Carnevali, F., Gigli, G., Lonardo, E., & Del Mercato, L. L. (2024). A 3D Pancreatic Cancer Model with Integrated Optical Sensors for Noninvasive Metabolism Monitoring and Drug Screening. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401138

Vancouver

Siciliano AC, Forciniti S, Onesto V, Iuele H, Cave DD, Carnevali F, et al. A 3D Pancreatic Cancer Model with Integrated Optical Sensors for Noninvasive Metabolism Monitoring and Drug Screening. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401138

BibTeX
@article{Siciliano2024,
  author = {Siciliano, Anna Chiara and Forciniti, Stefania and Onesto, Valentina and Iuele, Helena and Cave, Donatella Delle and Carnevali, Federica and Gigli, Giuseppe and Lonardo, Enza and Del Mercato, Loretta L},
  title = {A 3D Pancreatic Cancer Model with Integrated Optical Sensors for Noninvasive Metabolism Monitoring and Drug Screening},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202401138}
}
Kostenlos starten →